Disc Medicine, Inc.
IRON
Clasificación en acciones
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Precio por acción
$75.39
Última sincronización: 2026-10-22
Capitalización bursátil
$2.89B
Cambio (1 día)
-0.80%
Cambio (1 año)
-9.92%
País
US
Comercio Disc Medicine, Inc. (IRON)
Categoría
Healthcare
Ganancias de Disc Medicine, Inc. (IRON)
Ganancias en Jun 2026 TTM: $-245.58M
Secondo gli ultimi rapporti finanziari di Disc Medicine, Inc., gli utili attuali della società sono $-245.58M. Nel 2024, la società ha registrato un utile di $-109.00M, una disminución en comparación con agli utili del 2023, che erano di $-76.33M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Disc Medicine, Inc. desde 2020 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $-245.58M | 15.94% |
| 2025 | $-211.82M | 94.33% |
| 2024 | $-109.00M | 42.80% |
| 2023 | $-76.33M | 63.00% |
| 2022 | $-46.83M | 30.19% |
| 2021 | $-35.97M | -11.92% |
| 2020 | $-40.84M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $5.27B | -2,247.95% |
US
|
|
| $-3.09B | 1,157.03% |
US
|
|
| $-4.02B | 1,535.41% |
AU
|
|
| $2.85B | -1,258.78% |
BE
|
|
| $1.95B | -894.31% |
NL
|
